Evenity (romosozumab-aqqg) for Postmenopausal Osteoporosis
Customize your policy alerts
Sign up for Bluecross Idaho Policy MP 5.01.675 alerts
Get alerted when Policy MP 5.01.675 changes without checking for updates manually.
Monitor payer policy activity
Medical-benefit coverage and prior authorization for Evenity in postmenopausal females with osteoporosis who meet specified fracture-risk, prior-therapy, combination-use, duration, and dosing requirements. Pharmacy-benefit requests are outside this policy's scope.
Blue Cross of Idaho added a new prescription-drug policy establishing coverage criteria for Evenity in postmenopausal women with osteoporosis.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.